<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01317368</url>
  </required_header>
  <id_info>
    <org_study_id>SM1-AS-2010</org_study_id>
    <secondary_id>2010-024153-36</secondary_id>
    <nct_id>NCT01317368</nct_id>
  </id_info>
  <brief_title>The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Following Radical Prostatectomy</brief_title>
  <official_title>The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Versus Wound Infiltration Versus Placebo Following Open Radical Prostatectomy, a Double Blinded, Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducted to evaluate different analgesic treatments effect following operation
      where the prostate gland is surgically removed.

      The different treatments the investigators wish to investigate is:

        1. Transversus Abdominis Plane (TAP) block.

           The TAP block is a rather new method, where a local anaesthetic is deposited between the
           two inner abdominal muscles. Between these muscles, the nerves that innervates the
           anterior part of the abdominal wall is situated.

        2. Wound infiltration

           In this method you deposit a local anaesthetic in the edges of the wound.

        3. Placebo

      No active local treatment is given.

      All patients who wish to participate will be allocated to one of three different treatment
      groups.

      Group 1:

      Will receive TAP block with a local anaesthetic and wound infiltration with saline.

      Group 2:

      Will receive wound infiltration with a local anaesthetic and TAP block with saline.

      Group 3:

      Will receive TAP block with saline and wound infiltration with saline.

      Beside this local treatment all patients will be given systemic Paracetamol (tablet) and
      Ibuprofen (tablet).

      In addition all patients will be given a pump containing morphine. The pump is connected to a
      button which the patient can activate when they experience pain. This enables the patient to
      control how much morphine he needs, following the operation.

      The hypothesis is that the TAP block is superior in reducing pain and thereby reducing
      morphine consumption compared to wound infiltration and placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>A mean visual analogue scale (VAS) pain score 4 hours after surgery when moving from a supine to sitting position between the group receiving active TAP block and the placebo group.</measure>
    <time_frame>4 hours postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS pain score at rest, recorded as a Area Under Curve (AUC/24h)</measure>
    <time_frame>Recorded 0-24 hours postoperative</time_frame>
    <description>This outcome is assessed 1, 2, 4, 6, 8, 20 and 24 hours postoperative, while the patient is supine in his bed.
This outcome is recorded in and compared between all three groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS pain score when moving from a supine to a sitting position, recorded as a Area under Curve (AUC/24h)</measure>
    <time_frame>Recorded 0-24 hours postoperative</time_frame>
    <description>This outcome is assessed 1, 2, 4, 6, 8, 20 and 24 hours postoperative. This outcome is recorded in and compared between all three groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>Recorded 0-24 hours postoperative</time_frame>
    <description>On a scale ranging none-mild-moderate-severe at 1, 2, 4, 6, 8, 20, 24 hours postoperative.
This outcome is recorded in and compared between all three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>Recorded at 0-24 hours postoperative</time_frame>
    <description>On a scale ranging none-mild-moderate-severe this outcome is assessed at 1, 2, 4, 6, 8, 20 and 24 hours postoperative.
This outcome is recorded in and compared between all three groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>Recorded 0-24 hours postoperative</time_frame>
    <description>The number of times the patient produces more than 10 mL of vomit. Recorded at the intervals 0-1, 1-2, 2-4, 4-6, 6-8, 8-20 and 20-24 hours postoperative This outcome is recorded in and compared between all three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>On-going morphine consumption</measure>
    <time_frame>Recorded 0-24 postoperative</time_frame>
    <description>Recorded at the intervals 0-1, 1-2, 2-4, 4-6, 6-8, 8-20 and 20-24 hours postoperative This outcome is recorded and compared between all three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulated morphine consumption</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>This outcome is recorded in and compared between all three groups.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TAP block with Ropivacaine
Wound infiltration with Saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wound infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TAP block with Saline.
Wound infiltration with Ropivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TAP block with Saline.
Wound infiltration with Saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naropine</intervention_name>
    <description>20 mL of 0,75% Naropin is deposited on each side (40 mL in total) in the TAP.
At the same time 40 mL of saline 0,9% will be deposited subcutaneously as wound infiltration.
Both procedures is carried out at the end of the surgery while the patient is still anaesthetized and only this once.</description>
    <arm_group_label>TAP block</arm_group_label>
    <other_name>Ropivacaine</other_name>
    <other_name>TAP block</other_name>
    <other_name>Wound infiltration</other_name>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naropine</intervention_name>
    <description>20 mL Saline 0,9% is deposited on each side (40 mL in total) in the TAP.
At the same time 40 mL Ropivacaine 0,75% will be deposited subcutaneously as wound infiltration.
Both procedures is carried out at the end of the surgery while the patient is still anaesthetized and only this once.</description>
    <arm_group_label>Wound infiltration</arm_group_label>
    <other_name>Ropivacaine</other_name>
    <other_name>TAP block</other_name>
    <other_name>Wound infiltration</other_name>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>20 mL 0,9% Saline is deposited on each side (40 mL in total) in the TAP.
At the same time 40 mL Saline 0,9% will be given as wound infiltration.
Both procedures is carried out at the end of the surgery while the patient is still anaesthetized and only this once.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Ropivacaine</other_name>
    <other_name>TAP block</other_name>
    <other_name>Wound infiltration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 18 and &lt; 35

          -  Patients who have given their informed consent and have fully understood the nature
             and limitations of the study

          -  Patient who is planned for radical prostatectomy

        Exclusion Criteria:

          -  Not able to cooperate to complete the study

          -  Is not able to speak and understand danish

          -  Allergy towards the drugs which is used in the study

          -  Daily use of strong opioids

          -  Infection at the injection area
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgitte Ruhnau, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology, Abdominal Centre, Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Department of Anaesthesiology, Abdominal Centre, Rigshospitalet</name>
      <address>
        <city>Copenhagen Ã˜</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2011</study_first_submitted>
  <study_first_submitted_qc>March 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2011</study_first_posted>
  <last_update_submitted>June 19, 2012</last_update_submitted>
  <last_update_submitted_qc>June 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Birgitte Ruhnau</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>Postoperative analgesic treatment</keyword>
  <keyword>TAP block</keyword>
  <keyword>Prostatectomy</keyword>
  <keyword>Double blinded randomized clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

